| Title | 常见抗肿瘤药物所致乙型肝炎病毒再激活的诊疗进展 |
| Author | |
| Publication Years | 2022
|
| DOI | |
| Source Title | |
| ISSN | 1001-9057
|
| Volume | 39Issue:7Pages:439-444 |
| Abstract | 乙型肝炎病毒(HBV)再激活(HBVr)是导致慢性乙型肝炎患者病情恶化的重要因素之一.近年来,在肿瘤领域,由于化疗药物、靶向药物、免疫检查点抑制剂(ICPIs)等的广泛应用,抗肿瘤药物所致HBVr受到越来越多的关注.本文主要介绍抗肿瘤药物所致HBVr的现状分析、发病机制、危险因素和临床表现,并探讨抗肿瘤治疗中HBVr的管理策略. |
| Keywords | |
| URL | [Source Record] |
| Language | Chinese
|
| SUSTech Authorship | First
|
| Data Source | WanFang
|
| WanFangID | lcnkzz202207002
|
| Citation statistics |
Cited Times [WOS]:0
|
| Document Type | Journal Article |
| Identifier | http://kc.sustech.edu.cn/handle/2SGJ60CL/401854 |
| Department | The Third People's Hospital of Shenzhen |
| Affiliation | 518112 广东省深圳市第三人民医院 南方科技大学第二附属医院肝病医学中心 |
| First Author Affilication | The Third People's Hospital of Shenzhen |
| First Author's First Affilication | The Third People's Hospital of Shenzhen |
| Recommended Citation GB/T 7714 |
蔡庆贤,罗芳,夏章,等. 常见抗肿瘤药物所致乙型肝炎病毒再激活的诊疗进展[J]. 临床内科杂志,2022,39(7):439-444.
|
| APA |
蔡庆贤,罗芳,夏章,陈志杰,&龚丝.(2022).常见抗肿瘤药物所致乙型肝炎病毒再激活的诊疗进展.临床内科杂志,39(7),439-444.
|
| MLA |
蔡庆贤,et al."常见抗肿瘤药物所致乙型肝炎病毒再激活的诊疗进展".临床内科杂志 39.7(2022):439-444.
|
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment